VHI at a glance
VALHI INC /DE/ (VHI, SEC CIK 59255) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as May 22, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), VALHI INC /DE/ (VHI) reported revenue of $2.1 billion (down 1.3% from FY2024) and a net loss of $57.6 million. Diluted EPS was -$2.02.
- As of September 30, 2026, 14 institutional investment managers tracked by SignalX reported holding VALHI INC /DE/ (VHI) shares worth $7.7 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $2.1B
- −1.3% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 14 funds
- $7.7M · +0 vs prior quarter
- Latest 8-K
- Nov 5, 2026
- Item 2.02 · Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model: Manufacturing and selling component products (security and marine components) and real estate development, primarily in the U.S.
- New strategic emphasis on mitigating tariff impacts by increasing electronic component purchases and implementing pricing adjustments in 2025
- Shift in Real Estate segment focus due to sale of water utility assets and nearing completion of residential planned community development by end of 2027
- Land sales revenue declined to $59.3M in 2025 from $71.5M in 2024 amid slowed development pace, yet operating income rose to $65.2M from $55.2M
- Noteworthy pension plan settlement loss of $28.7M in Q4 2025 related to U.S. pension buy-out, significantly increasing net periodic pension expense for the year
Management Discussion & Analysis
- Revenue $1.86B in 2025, down 1% YoY from $1.89B in 2024; Chemicals segment net sales decreased $27.7M (1%)
- Chemicals segment operating loss $24.5M in 2025 vs operating income $138.5M in 2024; gross margin 11% vs 19%
- Best performing segment: Real Estate Management and Development (positive impact from tax increment reimbursements $34.2M in 2025)
- Worst performing segment: Chemicals with 2025 operating loss $24.5M vs income $138.5M in 2024, impacted by lower TiO2 prices and fixed costs
- Cash flow: Not explicitly detailed, but restructuring charges $10.3M, pension plan settlement loss $28.7M, no buybacks/dividends/capex disclosed
- 2026 outlook: Expect higher consolidated operating income driven by Chemicals segment due to higher sales volumes, selling prices, and lower costs; risks include economic uncertainty and geopolitical tensions
AI summary of the VHI 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No new risk factors disclosed, with Item 1A providing no material changes from the 2025 10-K
- German tax assessments: 2019 through 2021 notices received in March 2026, with $2.0 million uncertain tax position recorded
- Environmental liabilities: NLI remains exposed to CERCLA and other cleanup claims, including approximately five sites with unestimable costs
- Chemicals market risk: segment sales concentrated in chemicals, representing $1,609.0 million of nine-month 2026 revenue
- Debt and liquidity: Kronos carries €426.174 million of 9.50% notes due 2029, while Valhi had $119.7 million facility availability
Management Discussion & Analysis
- Q3 net income $30.2M vs $22.2M loss YoY, driven by Chemicals operating income $60.5M vs $15.9M loss
- Chemicals revenue $541.1M, up 18% YoY from $456.9M; gross margin 23% vs 10%
- Component Products strongest segment: sales $44.0M vs $40.0M, operating income $6.4M vs $4.8M
- Operating cash flow $71.7M through nine months vs $136.1M use; capital expenditures $42.9M
- Outlook: 2026 sales, volumes and margins above 2025; headwinds include weak demand, tariffs and economic uncertainty
AI summary of the VHI 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item EX-99.1: Item EX-99.1
- Q3 2026 net income $30.2M, or $1.06/share, versus $22.2M loss, or $0.78/share, in Q3 2025
- Nine-month net income $54.5M, or $1.91/share, versus $4.4M loss, or $0.15/share, in 2025
Item 2.02: Results of Operations and Financial Condition
- Item 2.02 contains no earnings release, financial results, or operating metrics for fiscal year 2026
- No investor-actionable performance information appears in the provided filing section
Item 7.01: Regulation FD Disclosure
- No substantive Regulation FD disclosure identified in the provided text
Item EX-99.2: Item EX-99.2
- Quarterly dividend $0.08 per share declared by Valhi’s board
- Payment scheduled for December 17, 2026
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results released August 6, 2026 through Exhibit 99.1
- Financial performance details reside in the attached press release, not the 8-K narrative
Item 7.01: Regulation FD Disclosure
- Valhi furnished an August 6, 2026 press release announcing a quarterly dividend
- Dividend details and payment terms appear in Exhibit 99.2
Item EX-99.1: Item EX-99.1
- Q2 net income attributable to Valhi stockholders surged to $22.3M, or $.78 per share, from $.9M, or $.03
- Chemicals drove the improvement, with operating income rising to $40.4M from $10.3M despite lower TiO₂ pricing
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Mary A. Tidlund resigning as Valhi director effective June 30, 2026
- Resignation not related to disagreement with Valhi
AI summaries of VHI 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for VHI
Don't miss the next VHI filing
- Alerts as it files. A push when VHI files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut VHI, by share count.
- Ask anything. An AI agent that reads every VHI filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Herrington Terri | A | May 21, 2026 | 3,150 | $12.66 |
| Norris Gina A. | A | May 21, 2026 | 3,150 | $12.66 |
| Hill Randy L | A | May 21, 2026 | 3,150 | $12.66 |
| Feehan Loretta J. | A | May 21, 2026 | 3,150 | $12.66 |
| Tidlund Mary A. | A | May 21, 2026 | 3,150 | $12.66 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $2.1B | $2.1B |
| Gross Profit | - | $424.5M | $295.4M |
| Operating Income | - | $210.7M | $63.3M |
| Net Income | - | $108.0M | -$57.6M |
| Gross Margin | - | 20.2% | 14.2% |
| Op. Margin | - | 10.0% | 3.0% |
| Net Margin | - | 5.1% | -2.8% |
| Balance Sheet | |||
| Total Assets | $2.7B | $2.8B | $2.6B |
| Equity | $935.8M | $1.0B | $1.0B |
| ROE | - | 10.4% | -5.6% |
| Per Share | |||
| EPS | - | $3.79 | $-2.02 |
| Cash Flow | |||
| Operating CF | - | $44.0M | -$35.5M |
| CapEx | - | $30.9M | $46.6M |
Source: XBRL data in VALHI INC /DE/ (VHI)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate VHI share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 14 | $7.7M |
| Q2 2026 | 14 | $7.4M |
| Q1 2026 | 14 | $6.8M |
| Q4 2025 | 15 | $6.1M |
| Q3 2025 | 13 | $8.4M |
| Q2 2025 | 15 | $8.7M |
| Q1 2025 | 15 | $6.4M |
| Q4 2024 | 11 | $8.6M |
- BNY Mellon+3.8K (+8%)
- BlackRock+1.9K (+1%)
- Morgan Stanley+771 (+21%)
- Vanguard Portfolio Management LLC+154 (+1%)
- PNC Financial Services+20 (+21%)
- Renaissance Technologies LLC−7.7K (-6%)
- Northern Trust−7.7K (-19%)
- Millennium Management−2.2K (-10%)
- Wells Fargo & Co−1.8K (-79%)
- Citigroup−1.1K (-83%)
- Bank of America Corp+11.5K
- AQR Capital Management+10.7K
- Citadel Advisors LLC−14.1K
- FMR LLC (Fidelity)−1.5K
Source: 13F-HR filings on SEC EDGAR (aggregated from 111 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
VHI filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 5, 2026 | - | Analysis | - |
| 10-Q | Nov 5, 2026 | Sep 30, 2026 | Analysis | |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 8-K | Jun 22, 2026 | - | Analysis | - |
| 4 | May 22, 2026 | - | - | |
| 4 | May 22, 2026 | - | - | |
| 4 | May 22, 2026 | - | - | |
| 4 | May 22, 2026 | - | - | |
| 4 | May 22, 2026 | - | - | |
| 8-K | May 21, 2026 | - | Analysis | |
| 8-K | May 7, 2026 | - | Analysis | |
| 10-Q | May 7, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Mar 10, 2026 | - | Analysis | - |
| 10-K | Mar 10, 2026 | Dec 31, 2025 | Analysis | |
| 8-K | Mar 5, 2026 | - | Analysis | - |
| 8-K | Dec 15, 2025 | - | - | |
| 10-Q | Nov 6, 2025 | Sep 30, 2025 | Analysis | |
| 10-Q | Aug 7, 2025 | Jun 30, 2025 | - | |
| 10-Q | May 8, 2025 | Mar 31, 2025 | - | |
| 10-K | Mar 6, 2025 | Dec 31, 2024 | - | |
| 10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
| 10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
| 10-Q | May 9, 2024 | Mar 31, 2024 | - | |
| 10-K | Mar 7, 2024 | Dec 31, 2023 | - |
Related Health Care companies
- KRO · KRONOS WORLDWIDE INCIndustrial Inorganic Chemicals
- LTBR · LIGHTBRIDGE CorpIndustrial Inorganic Chemicals
- LXU · LSB INDUSTRIES, INC.Industrial Inorganic Chemicals
- LXFR · LUXFER HOLDINGS PLCIndustrial Inorganic Chemicals
- NL · NL INDUSTRIES INCIndustrial Inorganic Chemicals
- TROX · Tronox Holdings plcIndustrial Inorganic Chemicals
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
VHI SEC filings: frequently asked questions
Which institutions hold VHI stock?
As of September 30, 2026, the largest VALHI INC /DE/ (VHI) holders among the 13F filers tracked by SignalX were BlackRock ($2.9 million), Renaissance Technologies LLC ($1.9 million), BNY Mellon ($779,000), State Street Corp ($588,000), Northern Trust ($502,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What was VHI's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), VALHI INC /DE/ (VHI) reported revenue of $2.1 billion (down 1.3% from FY2024) and a net loss of $57.6 million. Diluted EPS was -$2.02. The figures come from the XBRL data in the 10-K.
What did VHI report in its latest 8-K?
VALHI INC /DE/ (VHI) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 2026 net income $30.2M, or $1.06/share, versus $22.2M loss, or $0.78/share, in Q3 2025.
What are the latest VHI SEC filings?
VALHI INC /DE/ (VHI) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on May 22, 2026.
What is VHI's SEC CIK number?
VALHI INC /DE/ (VHI)'s SEC Central Index Key (CIK) is 59255. EDGAR lists every VHI filing under that number.
Ask anything about VHI
The research agent reads VHI's filings, financials, insider trades and 13F holders, then answers with sources.